Status:

COMPLETED

A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia

Lead Sponsor:

Biojiva LLC

Conditions:

Friedreich's Ataxia

Eligibility:

All Genders

12-50 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to assess the Efficacy, Long Term Safety and Tolerability of RT001 in subjects with Friedreich's Ataxia

Detailed Description

This is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, tolerability, in subjects with FRDA following the oral administration of study drug (active or placebo ca...

Eligibility Criteria

Inclusion

  • Key
  • Male or female 12 to 50 years of age
  • Medical history consistent with the symptoms of FRDA at ≤ 25 years of age
  • Detection of biallelic pathogenic variants in frataxin gene (FXN)
  • Ambulatory (with or without assistive device) and capable of performing other assessments/evaluations.
  • Must be able to walk 25 feet during the timed 1-minute walk
  • Key

Exclusion

  • Received treatment with other experimental therapies within the last 30 days prior to the first dose
  • Previously participated in the RT001 trial
  • Refusal to discontinue fish oils or other oil-based supplements for the duration of the study (Screening till last study procedure completed)
  • History of malignancies (other than basal cell carcinomas)
  • Inability to complete CPET protocol
  • Female who is breastfeeding or has a positive pregnancy test
  • History of uncontrolled diabetes mellitus (Type 1 or 2)

Key Trial Info

Start Date :

October 30 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 23 2021

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT04102501

Start Date

October 30 2019

End Date

August 23 2021

Last Update

May 27 2022

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Collaborative Neuroscience Network, LLC

Long Beach, California, United States, 90806

2

UCLA

Los Angeles, California, United States, 90095

3

University of Florida

Gainesville, Florida, United States, 32608

4

USF Ataxia Research Center

Tampa, Florida, United States, 33612